Role of APOE genotype in gait decline and disability in aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 11, 2013, Pages 1395-1401

  Verghese, Joe ^a,b,c   Holtzer, Roee ^a,c   Wang, Cuiling ^a,c   Katz, Mindy J ^a,c   Barzilai, Nir ^b,c   Lipton, Richard B ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c YESHIVA UNIVERSITY   (United States)

Author keywords

Disability; Epidemiology; Gait; Genetics

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ARTICLE; DISABILITY; EPIDEMIOLOGY; FEMALE; GAIT; GENETICS; GENETICS.; GENOTYPE; HUMAN; MALE; PHYSIOLOGY; VERY ELDERLY;

DISABILITY; EPIDEMIOLOGY; GAIT; GENETICS.;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEINS E; DISABILITY EVALUATION; FEMALE; GAIT; GENOTYPE; HUMANS; MALE;

EID: 84885983414     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt115     Document Type: Article

References (34)

1. Montero-Odasso M, Schapira M, Soriano ER, et al. Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 2005;60:1304-1309.
2. Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51:314-322.
3. Verghese J, Holtzer R, Oh-Park M, Derby CA, Lipton RB, Wang C. Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci. 2011;66:1083-1089.
4. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011;10:241-252.
5. Haan MN, Mayeda ER. Apolipoprotein E genotype and cardiovascular diseases in the elderly. Curr Cardiovasc Risk Rep. 2010;4:361-368.
6. Shah RC, Wilson RS, Bienias JL, Arvanitakis Z, Evans DA, Bennett DA. Blood pressure and lower limb function in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:839-843.
7. Buchman AS, Boyle PA, Wilson RS, Beck TL, Kelly JF, Bennett DA. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis Assoc Disord. 2009;23:63-69.
8. Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol. 2000;57:1561-1565.
9. Carmelli D, DeCarli C, Swan GE, et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci. 2000;55:M103-M109.
10. Melzer D, Dik MG, van Kamp GJ, Jonker C, Deeg DJ. The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J Gerontol A Biol Sci Med Sci. 2005;60:1319-1323.
11. Blazer DG, Fillenbaum G, Burchett B. The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. J Gerontol A Biol Sci Med Sci. 2001;56:M785-M789.
12. Rockwood K, Nassar B, Mitnitski A. Apolipoprotein E-polymorphism, frailty and mortality in older adults. J Cell Mol Med. 2008;12(6B):2754-2761.
13. Lan TY, Chang WC, Lan TH, Hurng BS. Apolipoprotein E genotype and risk of developing physical limitations in elderly people. J Am Geriatr Soc. 2009;57:1308-1309.
14. Himann JE, Cunningham DA, Rechnitzer PA, Paterson DH. Age-related changes in speed of walking. Med Sci Sports Exerc. 1988;20:161-166.
15. Reinvang I, Winjevoll IL, Rootwelt H, Espeseth T. Working memory deficits in healthy APOE epsilon 4 carriers. Neuropsychologia. 2010;48:566-573.
16. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging. 2009;30:1545-1551.
17. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305:50-58.
18. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
19. Sanders AE, Wang C, Katz M, et al. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA. 2010;303:150-158.
20. Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78:929-935.
21. Verghese J, Holtzer R, Lipton RB, Wang C. Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci. 2009;64:896-901.
22. Verghese J, Xue X. Predisability and gait patterns in older adults. Gait Posture. 2011;33:98-101.
23. Gill TM, Allore HG, Holford TR, Guo Z. Hospitalization, restricted activity, and the development of disability among older persons. JAMA. 2004;292:2115-2124.
24. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
25. Blanco I, Verghese J, Lipton RB, Putterman C, Derby CA. Racial differences in gait velocity in an urban elderly cohort. J Am Geriatr Soc. 2012;60:922-926.
26. Brach JS, Perera S, Studenski S, Katz M, Hall C, Verghese J. Meaningful change in measures of gait variability in older adults. Gait Posture. 2010;31:175-179.
27. Small BJ, Rosnick CB, Fratiglioni L, Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging. 2004;19:592-600.
28. Verghese J, Holtzer R, Lipton RB, Wang C. Mobility stress test approach to predicting frailty, disability, and mortality in high-functioning older adults. J Am Geriatr Soc. 2012;60:1901-1905.
29. Albert SM, Gurland B, Maestre G, Jacobs DM, Stern Y, Mayeux R. APOE genotype influences functional status among elderly without dementia. Am J Med Genet. 1995;60:583-587.
30. Bader G, Zuliani G, Kostner GM, Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo-and nonagenarians. Gerontology. 1998;44:293-299.
31. Rosen VM, Bergeson JL, Putnam K, Harwell A, Sunderland T. Working memory and apolipoprotein E: what's the connection? Neuropsychologia. 2002;40:2226-2233.
32. Laczó J, Andel R, Vlček K, et al. Spatial navigation and APOE in amnestic mild cognitive impairment. Neurodegener Dis. 2011;8:169-177.
33. Flory JD, Manuck SB, Ferrell RE, Ryan CM, Muldoon MF. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet. 2000;96:707-711.
34. Qiu C, Kivipelto M, Agüero-Torres H, Winblad B, Fratiglioni L. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry. 2004;75:828-833.